SCHEMBL19254963

SCHEMBL19254963

CSc1[nH]nnc1C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11474731 0.69 — —
SCHEMBL10029554 0.67 — —
SCHEMBL19604174 0.67 — —
SCHEMBL19589354 0.64 SMPD3 (0.30) —
SCHEMBL20077039 0.61 — —
SCHEMBL5321218 0.61 ALDH1A1 (0.33) —
SCHEMBL20077380 0.58 TRPA1 (0.33) —
SCHEMBL9479124 0.55 — —
SCHEMBL24950422 0.53 — —
SCHEMBL14446884 0.53 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200353076-A1 ANTI-FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES SUTRO BIOPHARMA, INC. 2020-11-12 — — US disclosed
US-9732161-B2 Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use SUTRO BIOPHARMA, INC. (US) 2017-08-15 — — US disclosed
Send feedback